Axxelent Pharma Science Private Limited, a active private limited company, was established on 07 October 2019 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110TN2019PTC131943. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹175.00 Cr and a paid-up capital of ₹61.67 Cr.
It upholds a compliant status. Employing 330 professional, Its leadership includes Sreenivasa Reddy Bhimanatham (Whole-Time Director), Sampath Kumar Devarajan (Director), Hariharan Subramanian (Director). Past directors included Vivekanand Parachur, Shankarlal Devendra, Hariharan Subramanian. It holds ₹305.96 Cr open charges and no settled loans. Its latest AGM occurred on 23 May 2025, with the balance sheet filed on 31 March 2025. It is based at No. 3 Jagadeeswaran Street, T.Nagar Chennai, Chennai, Tamil Nadu, 600017.
U24110TN2019PTC131943
131943
07 October 2019
₹175.00 Cr
₹61.67 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Axxelent Pharma Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreenivasa Reddy Bhimanatham | Whole-Time Director | 04 Dec 2020 | Current |
| Sampath Kumar Devarajan | Director | 07 Oct 2019 | Current |
| Hariharan Subramanian | Director | 01 Jul 2021 | Current |
| Kamlesh Phulwani | Nominee Director | 10 Apr 2023 | Current |
| Chaitanya Devandra | Whole-Time Director | 22 Apr 2022 | Current |
| Jitesh Devendra | Managing Director | 04 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 04 Dec 2020 | Past |
| Pramod Abcsdd | Director | 03 May 2021 | Past |
| Pramod Abcsdd | Additional Director | 06 Sep 2021 | Past |
| Pramod Abcsdd | Managing Director | 22 Apr 2022 | Past |
| Pramod Abcsdd | Cfo | - | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axxelent Pharma Science Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 237.33% increase. The company also saw a substantial improvement in profitability, with a 163.89% increase in profit. The company's net worth Soared by an impressive increase of 434.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2025, Axxelent Pharma Science had a promoter holding of 26.78% and a public holding of 73.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,059,577,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2025 | Others | ₹100.00 Cr | Open |
| 07 Jul 2025 | Others | ₹30.00 Cr | Open |
| 13 Dec 2023 | Hdfc Bank Limited | ₹2.46 M | Open |
| 30 Sep 2020 | Hdfc Bank Limited | ₹175.71 Cr | Open |
Explore comprehensive loan charge details -
Axxelent Pharma Science has a workforce of 330 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Axxelent Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axxelent Pharma Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ramesh was appointed as a Cfo was appointed as a Cfo on 17 Sep 2025 & has been associated with this company since 3 months 10 days . was documented.
Progress on A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101132515 was registered on 07 Jul 2025. was documented.
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101132490 was registered on 07 Jul 2025. was recorded as a recent event.
Axxelent Pharma Science Private Limited last Annual general meeting of members was held on 23 May 2025 as per latest MCA records. was recorded as a recent event.
Axxelent Pharma Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100900286 was registered on 13 Dec 2023. was recorded as a recent event.
The CIN of Axxelent Pharma Science Private Limited is U24110TN2019PTC131943.
Axxelent Pharma Science Private Limited is headquartered at No. 3 Jagadeeswaran Street, T.Nagar Chennai, Chennai, Tamil Nadu, 600017.
Axxelent Pharma Science Private Limited was incorporated on 07 October 2019.
The current directors of Axxelent Pharma Science Private Limited are
The primary industry of Axxelent Pharma Science Private Limited is Manufacturing.
Axxelent Pharma Science Private Limited is unlisted.
The authorized capital of Axxelent Pharma Science Private Limited is ₹175.00 Cr, and the paid-up capital is ₹61.67 Cr.
The compliance status of Axxelent Pharma Science Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX